Globus Medical GMED Contingent consideration fair value adjustments
Contingent consideration fair value adjustments at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's contingent consideration fair value adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Globus Medical's contingent consideration fair value adjustments?
- Globus Medical (GMED) reported contingent consideration fair value adjustments of $6.35M in Q1 2026.
- How has Globus Medical's contingent consideration fair value adjustments changed year-over-year?
- Globus Medical's contingent consideration fair value adjustments increased by 3703.6% year-over-year, from $167K to $6.35M.
- What is the long-term trend for Globus Medical's contingent consideration fair value adjustments?
- Over 2 years (2021 to 2023), Globus Medical's contingent consideration fair value adjustments has grown at a 1.8% compound annual growth rate (CAGR), from $16.81M to $17.43M.